TDX ACETAMINOPHEN— 510(k) K840941

Name: FDA 510(k) clearance K840941
Creator: U.S. Food and Drug Administration
Published: 1984-05-11

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K840941 for TDX ACETAMINOPHEN, Substantially Equivalent on 1984-05-11. Applicant: Abbott Laboratories. Device class: 2.

Clearance details

Applicant: Abbott Laboratories
Product code: Code LDP
Device class: Class 2
Regulation: 21 CFR 862.3030
Advisory panel: Clinical Toxicology
Date received: 1984-03-05
Decision date: 1984-05-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LDP

view all

K261364 — Atellica CH Acetaminophen 2 (ACTM)2026-07-24
K202644 — Acetaminophen2022-02-18
K180835 — SEKURE Acetaminophen L3K Assay2019-02-08
K110726 — ROCHE ACETAMINOPHEN ASSAY2011-12-23
K100200 — ADVIA CHEMISTRY ACETAMINOPHEN REAGENT, MODEL REF 079891382010-08-02

More clearances from Abbott Laboratories

view all

K252424 — Anti-HCV Next2026-04-28
K243500 — ARCHITECT iGentamicin2025-07-09
K243168 — Alinity i Rubella IgG2025-06-20
K243283 — Alinity h-series System2025-02-20
K233932 — Alinity i Toxo IgM2024-08-30

Adverse events under product code LDP

product code LDP

Other: 1
Total: 1

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.